Status:
COMPLETED
Effectiveness of Influenza Vaccine Reminder Systems
Lead Sponsor:
Kaiser Permanente
Conditions:
Asthma
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
19-64 years
Phase:
NA
Brief Summary
Influenza disease causes significant morbidity and mortality in the Unites States each year. Although influenza can cause morbidity in otherwise healthy individuals, adults with chronic lung disease h...
Detailed Description
At KPCO, postcards are typically sent to members each fall, to remind members to receive their annual influenza vaccine. At KPCO, interactive voice response (IVR) systems have been utilized for a numb...
Eligibility Criteria
Inclusion
- Age 19 to 64 years
- Enrolled in Kaiser Permanente Colorado health plan
- Diagnosis of asthma and/or chronic obstructive pulmonary disease
Exclusion
- Subjects living in households with other individuals in high-risk categories for influenza morbidity
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
12255 Patients enrolled
Trial Details
Trial ID
NCT01852656
Start Date
September 1 2012
End Date
April 1 2013
Last Update
May 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Colorado
Denver, Colorado, United States, 80237